GSK2163632A is a selective G protein-coupled receptor kinase (GRK) inhibitor used as a chemical probe for studying heart failure and Parkinson’s disease; it effectively inhibits GRK1 and GRK5 with modest selectivity and occupies a novel region of the GRK active site cleft, offering potential for achieving greater selectivity in GRK inhibitor design.